Thermosome

Thermosome is a biopharmaceutical company developing drug candidates by leveraging its proprietary drug delivery technology, which exploits a mechanism of action called intravascular drug release. Its technology platform is tailored for treating localized diseases, in which the activity of traditional systemically administered drugs is limited due to insufficient drug delivery into the target tissue and/or effective dosing is hindered by systemic side effects. Thermosome focuses on cancer patients with locally-advanced solid tumors.